Erythrasma pathophysiology

Jump to navigation Jump to search

Erythrasma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Erythrasma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Erythrasma pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

slides

Images

American Roentgen Ray Society Images of Erythrasma pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Erythrasma pathophysiology

on Erythrasma pathophysiology

Erythrasma pathophysiology in the news

Blogs on Erythrasma pathophysiology

Directions to Hospitals Treating Erythrasma

Risk calculators and risk factors for Erythrasma pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Luke Rusowicz-Orazem, B.S.

Overview

Erythrasma develops when Corynebacterium minitissium infiltrates the stratum corneum and proliferates. Hyperkeratosis leads to the formation of reddish-brown lesions characteristic of erythrasma. Microscopic pathology of erythrasma includes thickening of stratum corneum, decreased electron density around intracellular bacteria and those in direct contact with the cell wall, and widening of intracelluar space, allowing bacterial invasion, and separation of the horny cells. Erythrasma is associated with dermatological conditions, including additional corynebacterium pathologies.

Pathophysiology

Pathogenesis

Microscopic Pathology

Associated Conditions

Erythrasma is associated with the following dermatological conditions:

References

  1. 1.0 1.1 Montes, Leopoldo F.; Black, S.H.; McBride, Mollie E. (1967). "Bacterial Invasion of the Stratum Corneum in Erythrasma". Journal of Investigative Dermatology. 49 (5): 474–485. doi:10.1038/jid.1967.168. ISSN 0022-202X.
  2. Raubitschek, F. (1962). "Mechanical versus chemical keratolysis by dermatophytes". Medical Mycology. 1 (2): 87–90. doi:10.1080/00362176285190191. ISSN 1369-3786.
  3. Montes LF, McBride ME, Johnson WP, Owens DW, Knox JM (1965). "Ultrastructural study of the host-bacterium relationship in erythrasma". J. Bacteriol. 90 (5): 1489–91. PMC 315839. PMID 5848336.
  4. Pinto M, Hundi GK, Bhat RM, Bala NK, Dandekeri S, Martis J, Kambil SM (2016). "Clinical and epidemiological features of coryneform skin infections at a tertiary hospital". Indian Dermatol Online J. 7 (3): 168–73. doi:10.4103/2229-5178.182351. PMC 4886587. PMID 27294050.
  5. Whittle CH (1932). "Tinea Versicolor of the Trunk and Groins Simulating Erythrasma". Proc. R. Soc. Med. 25 (8): 1318–9. PMC 2184180. PMID 19988837.
  6. Kalra MG, Higgins KE, Kinney BS (2014). "Intertrigo and secondary skin infections". Am Fam Physician. 89 (7): 569–73. PMID 24695603.
  7. Holdiness MR (2002). "Management of cutaneous erythrasma". Drugs. 62 (8): 1131–41. PMID 12010076.